Living with Rheumatoid Arthritis 2016 is a new syndicated report which offers low-cost, high-value quantitative insight into patient attitudes and behaviour.
RA is a progressive and debilitating disease which affects around 3m people in Europe. The RA market is about to undergo significant changes in the next few years as newer entrants with novel modes of action complete with established brands, and biosimilars become accepted for use as cheaper alternatives to the branded biologics.
The full PowerPoint report, which includes a patient segmentation analysis, will be available early March 2016.
Register to find out how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes. Research Partnership
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space. Research Partnership
Learn about a new behavioural science-led framework incorporating AI technologies that ensures you get a true reflection of how your communications materials are consumed and processed by customers Research Partnership